Evelyne Le Roux - Concepedia

Author

Evelyne Le Roux

Vaincre la Mucoviscidose

Also Known As

E Roux, E. Le Roux, E. Roux, Elodie Roux, Emmanuelle Roux, Evelyne Le Roux, Evelyne Roux

Publications

746

Citations

H-Index

Concepts

All Affiliations

Vaincre la Mucoviscidose Institut national d'études démographiques Inserm Hôpital Foch Assistance Publique – Hôpitaux de Paris

About

Evelyne Le Roux is an author at Vaincre la Mucoviscidose specializing in medicine, pathology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	517
2	Natural Sciences	1	1	54
3	Public Health	1	1	63
4	Biochemistry	1	1	54
5	Epidemiology	1	1	63

Evelyne Le Roux

Publications

731

Citations

H-Index

Page 1

	Year	Citations
Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France Anne‐Laure Roux, Émilie Catherinot, Fabienne Neulat-Ripoll, Journal of Clinical Microbiology Pulmonary TuberculosisMicrobial DiseaseClinical EpidemiologyPathologyMabsc Species	2009	297
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations Émilie Catherinot, Anne‐Laure Roux, Marie‐Anne Vibet, Journal of Cystic Fibrosis Medical MicrobiologyMicrobial DiseaseMycobacterium AviumPathologyMicrobiology	2012	103
Continuous versus Intermittent Infusions of Ceftazidime for Treating Exacerbation of Cystic Fibrosis D. Hubert, Evelyne Le Roux, Thibaud Lavrut, Antimicrobial Agents and Chemotherapy	2009	75
Cystic fibrosis mortality trends in France Gil Bellis, Marie-Hélène Cazes, Alain Parant, Journal of Cystic Fibrosis Epidemiological TrendDisease ProgressionEpidemiological OutcomeClinical EpidemiologyInternational Health	2006	63
Acquired C1 inhibitor deficiency as a result of an autoantibody to the reactive center region of C1 inhibitor. Robert J. Mandle, Carl B. Baron, Evelyne Le Roux, The Journal of Immunology Inhibitory ActivityMedicinal ChemistryAutoimmune DiseaseBiochemistryC1inh Deficiency	1994	54
Long-Term Noninvasive Ventilation in Patients with Cystic Fibrosis Brigitte Fauroux, Evelyne Le Roux, S. Ravilly, Respiration	2007	53
Inhaled therapies, azithromycin and<i>Mycobacterium abscessus</i>in cystic fibrosis patients Émilie Catherinot, Anne‐Laure Roux, Marie‐Anne Vibet, European Respiratory Journal	2012	35
Triple Therapy with Sucralfate is as Effective as Triple Therapy Containing Bismuth in Eradicating Helicobacter pylori and Reducing Duodenal Ulcer Relapse Rates J. A. Louw, J. Žák, W Lucke, Scandinavian Journal of Gastroenterology	1992	32
Lack of Association Between Antiphospholipid Antibodies and Migraine Dimitrios A. Tsakiris, Ludwig Kappos, Guido Reber, Thrombosis and Haemostasis	1993	19

Page 1